Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blue LED therapy for recurrent vulvovaginal candidiasis
NCT05795491Completed
- Sponsor
- Cairo University
- Start
- Apr 2023
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in vulvovaginal candidiasis (VVC), sponsored by Cairo University. Primary endpoint: Vaginal swab culture at 2 months. Started Apr 2023; status: completed.
02
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT05795491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05795491.